N4-acylcytosine nucleosides for treatment of viral infections

C - Chemistry – Metallurgy – 07 – H

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07H 19/06 (2006.01) A61K 31/7068 (2006.01) A61P 31/12 (2006.01) A61P 31/14 (2006.01) A61P 31/18 (2006.01) C07H 19/16 (2006.01)

Patent

CA 2470255

The present invention is directed to a method and composition of treating or preventing viral infections, in particular, human immunodeficiency virus (HIV) and hepatitis B virus (HBV) infections, in human patients or other animals hosts, comprising the administration of N4-acyl-2',3'-dideoxy-5- flluorocytidine or N4-acyl-2',3'-didehydro-2',3' dideoxy-5-fluorocytidine, and pharmaceutically acceptable salts, prodrugs, and other derivatives thereof.

L'invention concerne un procédé et une composition de traitement ou de prévention d'infections virales, notamment des infections par le virus de l'immunodéficience humaine (VIH) et par le virus de l'hépatite B (VHB), chez des patients humains ou d'autres hôtes animaux. Ledit procédé consiste à administrer de la N?4¿-acyl-2',3'-didésoxy-5-fluorocytidine ou de la N?4¿-acyl-2',3'-didéhydro-2',3' didésoxy-5-fluorocytidine, ainsi que des sels acceptables au plan pharmaceutique, des promédicaments et d'autres dérivés.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

N4-acylcytosine nucleosides for treatment of viral infections does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with N4-acylcytosine nucleosides for treatment of viral infections, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N4-acylcytosine nucleosides for treatment of viral infections will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1455167

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.